Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Friday, Feb. 20, 2015, 91 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $98.84 to $10,479,200.00.

Highlighted Stocks Traded by Insiders:

Huntsman (HUN) - FREE Research Report

Stryker David M, who is Exec VP, GC and Sec at Huntsman, bought 170 shares at $22.27 on Feb. 20, 2015. Following this transaction, the Exec VP, GC and Sec owned 52,419 shares meaning that the stake was boosted by 0.33% with the 170-share transaction.

The shares most recently traded at $22.53, up $0.26, or 1.15% since the insider transaction. Historical insider transactions for Huntsman go as follows:

  • 4-Week # shares bought: 450,000
  • 4-Week # shares sold: 10,000
  • 12-Week # shares bought: 450,000
  • 12-Week # shares sold: 10,000
  • 24-Week # shares bought: 450,000
  • 24-Week # shares sold: 10,000

The average volume for Huntsman has been 4.4 million shares per day over the past 30 days. Huntsman has a market cap of $5.5 billion and is part of the basic materials sector and chemicals industry. Shares are down 1.54% year-to-date as of the close of trading on Friday.

Huntsman Corporation, together with its subsidiaries, manufactures and sells differentiated organic and inorganic chemical products worldwide. The company operates in five segments: Polyurethanes, Performance Products, Advanced Materials, Textile Effects, and Pigments. The stock currently has a dividend yield of 2.21%. The company has a P/E ratio of 16.9. Currently, there are 7 analysts who rate Huntsman a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HUN - FREE

TheStreet Quant Ratings rates Huntsman as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, reasonable valuation levels, good cash flow from operations and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Huntsman Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Misonix (MSON) - FREE Research Report

Oneill Thomas F, who is Director at Misonix, sold 3,700 shares at $12.43 on Feb. 20, 2015. Following this transaction, the Director owned 11,300 shares meaning that the stake was reduced by 24.67% with the 3,700-share transaction.

The shares most recently traded at $12.47, up $0.04, or 0.29% since the insider transaction. Historical insider transactions for Misonix go as follows:

  • 4-Week # shares bought: 45,000
  • 4-Week # shares sold: 32,775
  • 12-Week # shares bought: 45,000
  • 12-Week # shares sold: 32,775
  • 24-Week # shares bought: 47,500
  • 24-Week # shares sold: 59,194

The average volume for Misonix has been 24,100 shares per day over the past 30 days. Misonix has a market cap of $93.2 million and is part of the health care sector and health services industry. Shares are down 0.97% year-to-date as of the close of trading on Friday.

Misonix, Inc., a surgical device company, designs, develops, manufactures, and markets minimally invasive ultrasonic surgical device products for spine surgery, skull-based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery, and other surgical applications. The company has a P/E ratio of 33.0. Currently, there are no analysts who rate Misonix a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MSON - FREE

TheStreet Quant Ratings rates Misonix as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, impressive record of earnings per share growth and compelling growth in net income. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Misonix Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Collectors Universe (CLCT) - FREE Research Report

Hall David G, who is President at Collectors Universe, sold 1,985 shares at $23.00 on Feb. 20, 2015. Following this transaction, the President owned 719,800 shares meaning that the stake was reduced by 0.28% with the 1,985-share transaction.

The shares most recently traded at $23.01, up $0.01, or 0.04% since the insider transaction. Historical insider transactions for Collectors Universe go as follows:

  • 4-Week # shares sold: 23,007
  • 12-Week # shares sold: 51,608
  • 24-Week # shares bought: 700
  • 24-Week # shares sold: 74,642

The average volume for Collectors Universe has been 38,900 shares per day over the past 30 days. Collectors Universe has a market cap of $208.9 million and is part of the services sector and diversified services industry. Shares are up 12.7% year-to-date as of the close of trading on Friday.

Collectors Universe Inc. provides third-party authentication, grading, and related services for rare and high-value collectibles consisting of coins, trading cards, sports memorabilia, and autographs. The stock currently has a dividend yield of 5.95%. The company has a P/E ratio of 24.5. Currently, there are no analysts who rate Collectors Universe a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CLCT - FREE

TheStreet Quant Ratings rates Collectors Universe as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, expanding profit margins and good cash flow from operations. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Collectors Universe Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null